{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:17:46Z","timestamp":1761707866193},"publisher-location":"Boston","reference-count":23,"publisher":"Kluwer Academic Publishers","isbn-type":[{"type":"print","value":"0306477572"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/0-306-48382-3_99","type":"book-chapter","created":{"date-parts":[[2006,2,18]],"date-time":"2006-02-18T15:57:40Z","timestamp":1140278260000},"page":"487-491","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of Ocular Manifestations of Beh\u00e7et\u2019s Disease"],"prefix":"10.1007","author":[{"given":"F.","family":"Davatchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"99_CR1","first-page":"2","volume":"1","author":"F. Davatchi","year":"1997","unstructured":"Davatchi, F., Shahram, F., Akbarian, M., et al., 1997, Beh\u00e7et\u2019s disease \u2014 Analysis of 3443 cases. APLAR J. Rheumatol. 1: 2\u20135.","journal-title":"APLAR J. Rheumatol."},{"key":"99_CR2","first-page":"298","volume-title":"Textbook of Clinical Rheumatology","author":"F. Davatchi","year":"1998","unstructured":"Davatchi, F., 1998, Beh\u00e7et\u2019s disease. In Textbook of Clinical Rheumatology (H.S. Howe, and P.H. Feng, eds.), National Arthritis Foundation, Singapore, pp. 298\u2013315."},{"key":"99_CR3","first-page":"1309","volume":"44","author":"F. Davatchi","year":"2001","unstructured":"Davatchi, F., Shahram, F., Chams, H., et al., 2001, Long-term outcome of vision in Beh\u00e7et\u2019s disease. Arthritis Rheum. 44: S1309.","journal-title":"Arthritis Rheum."},{"key":"99_CR4","first-page":"493","volume-title":"Adamantiades-Beh\u00e7et\u2019s disease","author":"F. Davatchi","year":"2003","unstructured":"Davatchi, F., Shahram, F., Chams, H., et al., 2003, The influence of the delay of aggressive treatment on the vision and its outcome in Beh\u00e7et\u2019s disease. In Adamantiades-Beh\u00e7et\u2019s disease (Ch.C. Zouboulis, ed.), Kluwer\/Plenum, London, pp. 493\u2013494."},{"key":"99_CR5","first-page":"555","volume-title":"Beh\u00e7et\u2019 s Disease. Basic and Clinical Aspects","author":"F. Davatchi","year":"1991","unstructured":"Davatchi, F., Shahram, F., Chams, H., et al., 1991, Pulse cyclophosphamide in ophthalmological manifestations of Beh\u00e7et\u2019s disease. In Beh\u00e7et\u2019 s Disease. Basic and Clinical Aspects (J.D. O\u2019Duffy, and E. Kokmen, eds.), Marcel Decker, New York, pp. 555\u2013561."},{"key":"99_CR6","first-page":"692","volume":"65","author":"F. Davatchi","year":"1998","unstructured":"Davatchi, F., Shahram, F., Chams, H., et al., 1998, Pulse cyclophosphamide for ocular manifestations of Beh\u00e7et\u2019s disease. Cohort study on 283 patients. Rev. Rheum. (Engl. Ed.) 65: 692.","journal-title":"Rev. Rheum. (Engl. Ed.)"},{"key":"99_CR7","first-page":"683","volume-title":"Beh\u00e7et\u2019s Disease","author":"F. Shahram","year":"1993","unstructured":"Shahram, F., Davatchi, F., Chams, H., et al., 1993, Low dose pulse cyclophosphamide LDP) in ophthalmologic lesions of Beh\u00e7et\u2019s disease. In Beh\u00e7et\u2019s Disease (B. Wechsler, and P. Godeau, eds.), Excerpta Medica, Amsterdam, pp. 683\u2013686."},{"key":"99_CR8","first-page":"119","volume-title":"APLAR Rheumatology 1992","author":"F. Shahram","year":"1992","unstructured":"Shahram, F., Davatchi, F., Chams, H., et al., 1992, Pulse cyclophosphamide versus pulse methotrexate in ophthalmological manifestations of Beh\u00e7et\u2019s disease. In APLAR Rheumatology 1992 (A. Nasution, J. Darmawan, and H. Isbagio, eds.), Churchill Livingstone, Tokyo, pp. 119\u2013122."},{"key":"99_CR9","unstructured":"Shahram, F., Davatchi, F., Chams, H., et al., 1990, Methotrexate in ocular Beh\u00e7et disease. Preliminary report. In First APLAR Symposium on the Therapy of Rheumatic Diseases, Seoul, Korea. Abstract FP-23."},{"key":"99_CR10","first-page":"356","volume":"41","author":"F. Davatchi","year":"1998","unstructured":"Davatchi, F., Shahram, F., Chams, H., et al., 1998, Methotrexate for ocular lesions of Beh\u00e7et\u2019s disease. Cohort study on 262 patients. Arthritis Rheum. 41: S356.","journal-title":"Arthritis Rheum."},{"key":"99_CR11","first-page":"635","volume-title":"Beh\u00e7et\u2019s Disease","author":"F. Shahram","year":"1993","unstructured":"Shahram, F., Davatchi, F., Chams, H., et al., 1993, Comparing 3 methods of cytotoxic therapy in ophthalmologic lesions of Beh\u00e7et\u2019s disease. In Beh\u00e7et\u2019s Disease (B. Wechsler, and P. Godeau, eds.), Excerpta Medica, Amsterdam, pp. 635\u2013640."},{"key":"99_CR12","first-page":"421","volume-title":"Beh\u00e7et\u2019s Disease","author":"F. Shahram","year":"1997","unstructured":"Shahram, F., Davatchi, F., Chams, H., et al., 1997, Cyclosporin in sever ocular lesions of Beh\u00e7et\u2019s disease. In Beh\u00e7et\u2019s Disease (M. Hamza, ed.), Pub Adoua, Tunis, pp. 421\u2013423."},{"key":"99_CR13","first-page":"898","volume-title":"Behcet\u2019s Disease","author":"F. Davatchi","year":"2000","unstructured":"Davatchi, F., Shahram, F., Chams, H., 2000, Azathioprine for the treatment of ophthalmological lesions of Beh\u00e7et\u2019s disease. In Behcet\u2019s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 898\u2013900."},{"key":"99_CR14","first-page":"926","volume-title":"Behcet\u2019s Disease","author":"F. Shahram","year":"2000","unstructured":"Shahram, F., Chams, H., Davatchi, F., et al., 2000, Combination therapy with low dose pulse cyclophosphamide and methotrexate in ocular lesions of Beh\u00e7et\u2019s disease. In Behcet\u2019s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 926."},{"key":"99_CR15","first-page":"217","volume":"39","author":"F. Davatchi","year":"1996","unstructured":"Davatchi, F., Shahram, F., Gharibdoost F., et al., 1996, Outcome analysis of ocular lesions in Beh\u00e7et\u2019s disease with 6 different therapeutic methods. Arthritis Rheum. 39: S217.","journal-title":"Arthritis Rheum."},{"key":"99_CR16","first-page":"16","volume-title":"Neuro-ophthalmic Beh\u00e7et\u2019s","author":"F. Davatchi","year":"1997","unstructured":"Davatchi, F., 1997, Neuro-ophthalmic Beh\u00e7et\u2019s. In APLAR 3\n                    rd\n                   Symposium on the Therapy of Rheumatic Diseases (T.P. Torralba, C.M. Amante, and S.T.G. Victorio-Navarra, eds.), Excerpta Medica, Hong Kong, pp. 16\u201317."},{"key":"99_CR17","unstructured":"Davatchi, F., 2000, Treatment of ocular manifestations of Beh\u00e7et\u2019s disease. In Proceedings of the 9\n                    th\n                   Asia Pacific League of Associations for Rheumatology Congress, Beijing, pp. 174\u2013176."},{"key":"99_CR18","first-page":"446","volume-title":"Behcet\u2019s Disease","author":"Y.D. Adler","year":"2000","unstructured":"Adler, Y.D., Krause, L., Foerster, M.H., et al., 2000, Treatment of ocular Adamantiades-Beh\u00e7et\u2019s disease with interferon-alpha. In Behcet\u2019s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 446\u2013447."},{"key":"99_CR19","first-page":"483","volume-title":"Behcet\u2019s Disease","author":"B. Wechsler","year":"2000","unstructured":"Wechsler, B., Huong-Boutin, L.T.D., Amoura, Z., et al., 2000, Efficacy of alpha interferon in severe and refractory uveitis of Beh\u00e7et\u2019s disease. In Behcet\u2019s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 483\u2013488."},{"key":"99_CR20","first-page":"491","volume-title":"Behcet\u2019s Disease","author":"I. K\u00f6tter","year":"2000","unstructured":"K\u00f6tter, I., St\u00fcbiger, N., Eckstein, A.K., et al., 2000, Recmbinant human interferon-\u03b12A (IFN\u03b12A) in the treatment of ocular Beh\u00e7et\u2019s disease (BD). In Behcet\u2019s Disease (D. Bang, E.-S. Lee, S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 491\u2013493."},{"key":"99_CR21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780280611","volume":"28","author":"R.B. Nussenblatt","year":"1985","unstructured":"Nussenblatt, R.B., Palestine, A.G., and Clan, C.C., 1985, Effectiveness of cyclosporin therapy for Beh\u00e7et\u2019s disease. Arthritis Rheum. 28: 671\u2013679.","journal-title":"Arthritis Rheum."},{"key":"99_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","volume":"118","author":"S.M. Whitcup","year":"1994","unstructured":"Whitcup, S.M., Salvo, E.C. Jr., and Nussenblatt. R.B., 1994, Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Beh\u00e7et\u2019s disease. Am. J. Ophthalmol. 118: 39\u201345.","journal-title":"Am. J. Ophthalmol."},{"key":"99_CR23","first-page":"66","volume":"40","author":"F. Davatchi","year":"1997","unstructured":"Davatchi, F., Shahram, F., Gharibdoost, F., et al., 1997, Outcome of patients with ocular lesions of Beh\u00e7et\u2019s disease non responding to classical treatments. Arthritis Rheum. 40: S66.","journal-title":"Arthritis Rheum."}],"container-title":["Advances in Experimental Medicine and Biology","Adamantiades-Beh\u00e7et\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-306-48382-3_99.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:31:26Z","timestamp":1619483486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-306-48382-3_99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["0306477572"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/0-306-48382-3_99","relation":{},"subject":[]}}